SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Adaptimmune Therapeutics PLC – IPO: ‘F-1’ on 4/6/15 – EX-21.1

On:  Monday, 4/6/15, at 5:01pm ET   ·   Accession #:  1047469-15-3218   ·   File #:  333-203267

Previous ‘F-1’:  None   ·   Next:  ‘F-1/A’ on 4/27/15   ·   Latest:  ‘F-1/A’ on 5/1/15   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/06/15  Adaptimmune Therapeutics PLC      F-1                   28:17M                                    Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement of a Foreign Private Issuer   —   Form F-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1         Registration Statement of a Foreign Private Issuer  HTML   2.05M 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML    600K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    652K 
12: EX-10.10    Material Contract                                   HTML    514K 
13: EX-10.11    Material Contract                                   HTML    158K 
14: EX-10.12    Material Contract                                   HTML    177K 
15: EX-10.13    Material Contract                                   HTML    180K 
16: EX-10.14    Material Contract                                   HTML    110K 
17: EX-10.15    Material Contract                                   HTML    281K 
18: EX-10.16    Material Contract                                   HTML    287K 
19: EX-10.17    Material Contract                                   HTML    167K 
20: EX-10.18    Material Contract                                   HTML    370K 
21: EX-10.19    Material Contract                                   HTML    158K 
 4: EX-10.2     Material Contract                                   HTML    928K 
22: EX-10.20    Material Contract                                   HTML    167K 
23: EX-10.21    Material Contract                                   HTML     70K 
24: EX-10.22    Material Contract                                   HTML     70K 
25: EX-10.23    Material Contract                                   HTML     72K 
 5: EX-10.3     Material Contract                                   HTML    229K 
 6: EX-10.4     Material Contract                                   HTML    315K 
 7: EX-10.5     Material Contract                                   HTML    629K 
 8: EX-10.6     Material Contract                                   HTML    329K 
 9: EX-10.7     Material Contract                                   HTML    414K 
10: EX-10.8     Material Contract                                   HTML    370K 
11: EX-10.9     Material Contract                                   HTML    123K 
26: EX-21.1     Subsidiaries of the Registrant                      HTML     10K 
27: EX-23.1     Consent of Experts or Counsel                       HTML     10K 
28: EX-23.2     Consent of Experts or Counsel                       HTML     10K 


EX-21.1   —   Subsidiaries of the Registrant


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 21.1

 

Subsidiary Name

 

Jurisdiction of Formation

Adaptimmune Limited

 

England and Wales

Adaptimmune LLC

 

Delaware

 




7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/06/24  Adaptimmune Therapeutics plc      10-K       12/31/23  131:16M                                    Toppan Merrill Bridge/FA
 4/18/23  Adaptimmune Therapeutics plc      S-4/A                  7:5.6M                                   Toppan Merrill/FA
 4/05/23  Adaptimmune Therapeutics plc      S-4                    7:4.5M                                   Toppan Merrill/FA
 3/06/23  Adaptimmune Therapeutics plc      10-K       12/31/22  117:15M                                    Toppan Merrill Bridge/FA
 3/14/22  Adaptimmune Therapeutics plc      10-K       12/31/21  109:13M                                    Toppan Merrill Bridge/FA
 2/25/21  Adaptimmune Therapeutics plc      10-K       12/31/20  112:13M                                    Toppan Merrill Bridge/FA
 4/17/15  SEC                               UPLOAD9/25/17    1:162K Adaptimmune Therapeutics plc
Top
Filing Submission 0001047469-15-003218   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 11:31:19.1pm ET